{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T15:19:54Z","timestamp":1769095194431,"version":"3.49.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1A5A2025286 NRF-2020M2D9A2093974"],"award-info":[{"award-number":["NRF-2018R1A5A2025286 NRF-2020M2D9A2093974"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Pulmonary fibrosis (PF) is a progressive lung disease characterized by fibroblast accumulation and collagen deposition, resulting in lung scarring and impaired gas exchange. Current treatments for idiopathic pulmonary fibrosis (IPF) have limited efficacy and significant side effects. Heat shock protein 27 (HSP27) has emerged as a potential therapeutic target for PF due to its involvement in fibrotic processes. However, effective HSP27 inhibitors for PF treatment are still lacking.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> To assess the anti-fibrotic effects of NA49, we utilized murine PF models induced by radiation (IR) or bleomycin (BLM). We administered NA49 to the PF mice and evaluated its impact on lung fibrosis progression. We also investigated the molecular mechanisms underlying NA49's effects, focusing on its inhibition of EMT-related signaling pathways.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> In our study, we evaluated the potential of a novel HSP27 inhibitor, NA49, in preclinical models of PF. NA49 effectively suppressed PF development in radiation and bleomycin-induced PF models. It reduced fibrosis, inhibited NFkB signaling, and downregulated EMT-related molecules. Importantly, we evaluated the safety profile of NA49 by assessing its impact on DNA strand breakage. Compared to previous HSP27 inhibitors, NA49 showed lower levels of DNA damage in human lung epithelial cells, and suggests that NA49 may have reduced toxicity compared to other HSP27 inhibitors. Overall, our results demonstrate that NA49 effectively inhibits PF development in preclinical models. It reduces lung fibrosis, inhibits EMT-related signaling pathways, and exhibits improved safety profiles. These findings highlight the potential of NA49 as a promising candidate for the treatment of PF.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> NA49 exhibited significant anti-fibrotic effects, inhibiting fibrosis development and EMT-related signaling pathways. Moreover, NA49 showed improved safety profiles compared to previous HSP27 inhibitors.<\/jats:p>","DOI":"10.3389\/fphar.2023.1203033","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T12:54:55Z","timestamp":1688475295000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Drug like HSP27 cross linkers with chromenone structure ameliorates pulmonary fibrosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Young Jo","family":"Yoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seulgi","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Yeon","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Gyeong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeseul","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Sook","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younghwa","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaeho","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Sil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/thoraxjnl-2013-204608","article-title":"Epithelial-mesenchymal transition in lung development and disease: Does it exist and is it important?","volume":"69","author":"Bartis","year":"2014","journal-title":"Thorax"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.2165\/11207710-000000000-00000","article-title":"Pirfenidone: In idiopathic pulmonary fibrosis","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"B35","doi-asserted-by":"publisher","first-page":"105372","DOI":"10.18632\/oncotarget.22192","article-title":"Sensitization of lung cancer cells by altered dimerization of HSP27","volume":"8","author":"Choi","year":"2017","journal-title":"Oncotarget"},{"key":"B3","doi-asserted-by":"publisher","first-page":"607483","DOI":"10.3389\/fcell.2020.607483","article-title":"The epithelial-to-mesenchymal transition as a possible therapeutic target in fibrotic disorders","volume":"8","author":"Di Gregorio","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-2613.2006.00484.x","article-title":"Heat shock protein 27: Its potential role in vascular disease","volume":"87","author":"Ferns","year":"2006","journal-title":"Int. J. Exp. Pathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1465-9921-8-37","article-title":"Antisense oligonucleotide inhibition of heat shock protein (HSP) 47 improves bleomycin-induced pulmonary fibrosis in rats","volume":"8","author":"Hagiwara","year":"2007","journal-title":"Respir. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.29245\/2689-999x\/2019\/2.1149","article-title":"Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial\/fibroblastic cross-talk","volume":"3","author":"Hill","year":"2019","journal-title":"J. Lung Health Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.ejmech.2017.08.065","article-title":"Synthesis and biological effect of chrom-4-one derivatives as functional inhibitors of heat shock protein 27","volume":"139","author":"Hwang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1465-9921-15-16","article-title":"Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis","volume":"15","author":"Inomata","year":"2014","journal-title":"Respir. Res."},{"key":"B9","first-page":"211","article-title":"Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis","volume":"289","author":"Iyer","year":"","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B10","first-page":"367","article-title":"Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis","volume":"291","author":"Iyer","year":"","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12929-023-00896-5","article-title":"The miR-15b-Smurf2-HSP27 axis promotes pulmonary fibrosis","volume":"30","author":"Jeon","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/09553002.2017.1235297","article-title":"Identification of radiation response genes and proteins from mouse pulmonary tissues after high-dose per fraction irradiation of limited lung volumes","volume":"93","author":"Jin","year":"2017","journal-title":"Int. J. Radiat. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: Novel roles and mediators","volume":"5","author":"Kendall","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"53178","DOI":"10.18632\/oncotarget.10629","article-title":"Overcoming HSP27-mediated resistance by altered dimerization of HSP27 using small molecules","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.1158\/1078-0432.CCR-18-3900","article-title":"The hsp27-mediated IkB\u03b1-nf?b signaling Axis promotes radiation-induced lung fibrosis","volume":"25","author":"Kim","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"45001","DOI":"10.1038\/srep45001","article-title":"Standardized herbal formula PM014 inhibits radiation-induced pulmonary inflammation in mice","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1074\/mcp.M300108-MCP200","article-title":"Transforming growth factor-beta 1 specifically induce proteins involved in the myofibroblast contractile apparatus","volume":"3","author":"Malmstr\u00f6m","year":"2004","journal-title":"Mol. Cell Proteomics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"26385","DOI":"10.3402\/ecrj.v2.26385","article-title":"Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine","volume":"2","author":"Myll\u00e4rniemi","year":"2015","journal-title":"Eur. Clin. Respir. J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"112225","DOI":"10.1016\/j.biopha.2021.112225","article-title":"HSPB1 inhibitor J2 attenuates lung inflammation through direct modulation of Ym1 production and paracrine signaling","volume":"143","author":"Oh","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ejphar.2008.06.046","article-title":"Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis","volume":"590","author":"Oku","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0148998","DOI":"10.1371\/journal.pone.0148998","article-title":"Heat shock protein 27 plays a pivotal role in myofibroblast differentiation and in the development of bleomycin-induced pulmonary fibrosis","volume":"11","author":"Park","year":"2016","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/jcb.21186","article-title":"Fibrosis and cancer: Do myofibroblasts come also from epithelial cells via EMT?","volume":"101","author":"Radisky","year":"2007","journal-title":"J. Cell Biochem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1164\/rccm.200602-163OC","article-title":"Incidence and prevalence of idiopathic pulmonary fibrosis","volume":"174","author":"Raghu","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1021\/jm501562a","article-title":"Nintedanib: From discovery to the clinic","volume":"58","author":"Roth","year":"2015","journal-title":"J. Med. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1158\/0008-5472.CAN-12-3979","article-title":"Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer","volume":"73","author":"Shiota","year":"2013","journal-title":"Cancer Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"100515","DOI":"10.1016\/j.xcrp.2021.100515","article-title":"The mechanics of fibrillar collagen extracellular matrix","volume":"2","author":"Sun","year":"2021","journal-title":"Cell Rep. Phys. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1172\/JCI116631","article-title":"Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats","volume":"92","author":"Westergren-Thorsson","year":"1993","journal-title":"J. Clin. Invest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1096\/fj.12-220053","article-title":"Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation","volume":"27","author":"Wettstein","year":"2013","journal-title":"Faseb J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/path.4126","article-title":"Inflammation, wound repair, and fibrosis: Reassessing the spectrum of tissue injury and resolution","volume":"229","author":"White","year":"2013","journal-title":"J. Pathol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: Pathogenesis, etiology and regulation","volume":"2","author":"Wilson","year":"2009","journal-title":"Mucosal Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J. Exp. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/pharmaceutics13050630","article-title":"Drug-like small molecule HSP27 functional inhibitor sensitizes lung cancer cells to gefitinib or cisplatin by inducing altered cross-linked Hsp27 dimers","volume":"13","author":"Yoo","year":"2021","journal-title":"Pharmaceutics"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1203033\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T12:54:59Z","timestamp":1688475299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1203033\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,4]]},"references-count":34,"alternative-id":["10.3389\/fphar.2023.1203033"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1203033","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,4]]},"article-number":"1203033"}}